Original Air Date: Thursday, January 18, 2018, 01:00pm EST
- Explain why people with mental health conditions (depression and ADHD, for example) and substance use disorders have been historically targeted by the tobacco industry.
- State whether adults with mental health conditions and substance use disorders smoke more than adults without those conditions.
- Describe the morbidity rates of people with mental health conditions and name specific causes of death that can be attributed to tobacco use.
- Explain the impact of the truth® campaign among its target audience.
- Describe evidence-based approaches for treating tobacco use and tobacco addiction in persons with co-occurring mental illness.
- Describe how you can leverage the National Behavioral Health Network for Tobacco & Cancer Control’s tools, resources, and network to combat tobacco use & cancer disparities among individuals with mental illnesses and addictions and network members.
CME/CEUs are available for participants who joined the LIVE session, on January 18, 2018. The CME/CEU registration site will close on January 28th 2018.
Please follow these instructions to claim credit:
1. Click here for the CME/CEU registration link: https://cmecalifornia.com/Activity/5989185/Detail.aspx
2. Click on the yellow box in the upper right hand corner of your screen which says “Select”, to choose this webinar
3. If you are a first time user, you will need to create an account, and if you are return user, enter in your username (email address) and password
4. Enter in Access Code: SCLC (case sensitive) add 8-digit live date – i.e. SCLC01182018
5. On the payment screen click on “discount code” and enter in SCLC10to waive the $45 certificate fee
6. Starting at the “Overview” tab read through all of the content and check the box at the bottom of the page to confirm that you have read the information.
7. Next on the “Content” tab, the webinar recording link is posted. You do not need to watch the webinar again. You can click on “Continue” to move to the next tab.
8. Next on the “Evaluation” tab, there is a short survey to complete. This is a CME requirement.
9. Lastly, once you are done, you will be able to print your certificate right away or download it as a PDF, on the “Certificate” tab.”
The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
UCSF designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Registered Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.
Physician Assistants: The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.
California Pharmacists: The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA category 1 credit™. If you are a pharmacist in another state, you should check with your state board for approval of this credit.
Accreditation for Respiratory Therapists
If you would like to claim CRCE credit, please email Jennifer Matekuare and include your AARC number and your state of residence.
This program has been approved for a maximum of 1.0 contact hour Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100 Irving TX 75063. Course # 150459000.
This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.
The following faculty speakers, moderators, and planning committee members have disclosed they have no financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity:
Ashley Persie, Margaret Jaco Manecke, MSSW, Christine Cheng, Brian Clark, Jennifer Matekuare, Roxana Said, MPH, Catherine Saucedo, and Steven A. Schroeder, MD
The following faculty speaker has disclosed a financial interest/arrangement or affiliation with a commercial company who has provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity. All conflicts of interest have been resolved in accordance with the ACCME Standards for Commercial Support:
Judith J. Prochaska PhD, MPH –
- Pfizer – Advisor or Reviewer, Consultant
- Carrot – Advisor or Reviewer, Consultant
- MD Revolution – Consultant
- Plaintiffs Law Firms – Lawsuits against tobacco companies, Consultant
- Visit https://truthinitiative.org to stay informed on these issues and to help spread the word
- Visit www.BHtheChange.org – The National Behavioral Health Network for Tobacco & Cancer Control’s (NBHN’s) website for resources
- Visit https://smokefree.gov/ – for tools and tips on quitting
- Visit www.changelabsolutions.org/tobacco-control for sample tobacco free policy language and much more
- Visit https://nonsmokersrights.org/ – Americans for Nonsmokers’ Rights (ANR’s) website for additional resources